切换导航
关闭
  • 菜单
  • Setting

Signaling Pathways - Selective - F1 Fo-ATPase - Sulfonylurea receptors - Topoisomerases

10 件产品

每页
清除全部
  1. Pirarubicin
    B2295 Pirarubicin
     1 Citation
    中文名: 吡柔比星
    Target: Topoisomerases
    Summary: 拓扑异构酶II抑制剂,蒽环类抗生素
      ≥7.65 mg/mL
      insoluble in H2O
  2. Tolbutamide
    B2194 Tolbutamide
    中文名: 甲苯磺丁脲
    Target: cAMP|Sulfonylurea receptors
    Summary: 第一代钾通道阻滞剂
      ≥10.05 mg/mL
      insoluble in H2O
  3. Irinotecan HCl Trihydrate
    B2293 Irinotecan HCl Trihydrate
    中文名: 盐酸依立替康三水合物
    Target: Topoisomerases
    Summary: 拓扑异构酶I抑制剂
      ≥23.1 mg/mL
      ≥2.5 mg/mL
  4. Beta-Lapachone
    B2290 Beta-Lapachone
    中文名: β-拉帕醌
    Target: Topoisomerases
    Summary: 选择性DNA拓扑异构酶I抑制剂
      ≥10.85 mg/mL
      insoluble in H2O
  5. BTB06584
    B3041 BTB06584
    Target: F1 Fo-ATPase
    Summary: F1F0 ATP合酶抑制剂
      ≥17.05 mg/mL
      insoluble in H2O
  6. Clinafloxacin CI96 AM1091
    A8400 Clinafloxacin CI96 AM1091
    中文名: 克林沙星
    Target: Topoisomerases
    Summary: 拓扑异构酶抑制剂
      ≥3.66 mg/mL
      insoluble in H2O
  7. Epirubicin HCl
    A2451 Epirubicin HCl
    中文名: 盐酸表阿霉素
    Target: Topoisomerases
    Summary: 抗生素类抗肿瘤药物
      ≥29.00 mg/mL
      ≥40.33 mg/mL
  8. Etoposide
    A1971 Etoposide
     4 Citation
    中文名: 依托泊苷
    Target: Topoisomerases
    Summary: 拓扑异构酶II(Topo II)抑制剂
      ≥29.45 mg/mL
      insoluble in H2O
  9. Doxorubicin (Adriamycin) HCl
    A1832 Doxorubicin (Adriamycin) HCl
     2 Citation
    中文名: 盐酸多柔比星,盐酸阿霉素
    Target: Topoisomerases
    Summary: 抗肿瘤抗生素,抑制TOPO II。
      ≥29 mg/mL
      ≥57.2 mg/mL
  10. Fostriecin sodium salt
    A4536 Fostriecin sodium salt
    Target: PP1|PP2A|Topoisomerases|PP4
    Summary: 抗肿瘤抗生素
      Soluble in H2O

10 件产品

每页